前瞻性随机对照研究:比较新型 Catfish 血流恢复装置和 Solitaire 支架回取器在急诊大血管闭塞性脑卒中血栓切除血管重建术中的应用。

IF 4.4 1区 医学 Q1 CLINICAL NEUROLOGY Stroke and Vascular Neurology Pub Date : 2023-12-29 DOI:10.1136/svn-2022-002036
Gang Luo, Xiaoyan Yan, Guodong Xiao, Liping Wei, Ya Li Kun Nai Bi Jiang, Rongyao Ma, Wenhuo Chen, Chun Fang, Zhiming Zhou, Jieqing Wan, Ya Peng, Guilian Zhang, Junfeng Zhao, Li Li, Haicheng Yuan, Jin Wu, Bing Li, Fan Zhang, Yuhong Cheng, Feng Gao, Zhongrong Miao
{"title":"前瞻性随机对照研究:比较新型 Catfish 血流恢复装置和 Solitaire 支架回取器在急诊大血管闭塞性脑卒中血栓切除血管重建术中的应用。","authors":"Gang Luo, Xiaoyan Yan, Guodong Xiao, Liping Wei, Ya Li Kun Nai Bi Jiang, Rongyao Ma, Wenhuo Chen, Chun Fang, Zhiming Zhou, Jieqing Wan, Ya Peng, Guilian Zhang, Junfeng Zhao, Li Li, Haicheng Yuan, Jin Wu, Bing Li, Fan Zhang, Yuhong Cheng, Feng Gao, Zhongrong Miao","doi":"10.1136/svn-2022-002036","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The Catfish stent retriever is a newly developed mechanical thrombectomy device for rapid recanalisation in emergent large vessel occlusion (ELVO) stroke. The current trial aimed to assess whether the Catfish stent retriever is non-inferior to the Solitaire stent retriever in terms of outcomes in ELVO stroke.</p><p><strong>Methods: </strong>This was a randomised, prospective, parallel-group, multicentre, open-label, non-inferiority study conducted at 18 sites in China. The primary outcome was the proportion of cases with successful recanalisation (modified thrombolysis in cerebral infarction score of 2b or 3) following the procedure. Secondary efficacy outcomes included the National Institutes of Health Stroke Scale scores at 24 hours and 7 days or discharge if earlier, time from artery puncture to successful recanalisation and good clinical outcome (modified Rankin scale score ≤2) at 90 days. Safety outcomes included symptomatic intracranial haemorrhage, all cause-death and severe adverse events at 90 days.</p><p><strong>Results: </strong>Between 3 March 2019 and 5 June 2021, 118 and 120 patients were randomly allocated to the Catfish and Solitaire groups, respectively. The primary endpoint after all endovascular procedures was non-inferior in the Catfish group (88.5%, 100/113) than in the Solitaire group (87.7%, 100/114), with a rate difference (RD) of 0.78% (95% CI -7.64 to -9.20; p=0.001). Sensitivity analysis only considering the per-protocol set also yielded similar results, with an RD of 0.83% (95% CI -7.03 to -8.70; p<0.001). Additionally, the proportions of cases with good clinical outcomes (47.8% vs 50.0%, p=0.739) and all-cause death rates (17.7% vs 18.8%, p=0.700) were similar in both groups at 90 days.</p><p><strong>Conclusions: </strong>The Catfish stent retriever is an effective and safe device for endovascular recanalisation in ELVO stroke.</p><p><strong>Trial registration number: </strong>NCT03820882.</p>","PeriodicalId":22021,"journal":{"name":"Stroke and Vascular Neurology","volume":" ","pages":"435-443"},"PeriodicalIF":4.4000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800261/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled study.\",\"authors\":\"Gang Luo, Xiaoyan Yan, Guodong Xiao, Liping Wei, Ya Li Kun Nai Bi Jiang, Rongyao Ma, Wenhuo Chen, Chun Fang, Zhiming Zhou, Jieqing Wan, Ya Peng, Guilian Zhang, Junfeng Zhao, Li Li, Haicheng Yuan, Jin Wu, Bing Li, Fan Zhang, Yuhong Cheng, Feng Gao, Zhongrong Miao\",\"doi\":\"10.1136/svn-2022-002036\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>The Catfish stent retriever is a newly developed mechanical thrombectomy device for rapid recanalisation in emergent large vessel occlusion (ELVO) stroke. The current trial aimed to assess whether the Catfish stent retriever is non-inferior to the Solitaire stent retriever in terms of outcomes in ELVO stroke.</p><p><strong>Methods: </strong>This was a randomised, prospective, parallel-group, multicentre, open-label, non-inferiority study conducted at 18 sites in China. The primary outcome was the proportion of cases with successful recanalisation (modified thrombolysis in cerebral infarction score of 2b or 3) following the procedure. Secondary efficacy outcomes included the National Institutes of Health Stroke Scale scores at 24 hours and 7 days or discharge if earlier, time from artery puncture to successful recanalisation and good clinical outcome (modified Rankin scale score ≤2) at 90 days. Safety outcomes included symptomatic intracranial haemorrhage, all cause-death and severe adverse events at 90 days.</p><p><strong>Results: </strong>Between 3 March 2019 and 5 June 2021, 118 and 120 patients were randomly allocated to the Catfish and Solitaire groups, respectively. The primary endpoint after all endovascular procedures was non-inferior in the Catfish group (88.5%, 100/113) than in the Solitaire group (87.7%, 100/114), with a rate difference (RD) of 0.78% (95% CI -7.64 to -9.20; p=0.001). Sensitivity analysis only considering the per-protocol set also yielded similar results, with an RD of 0.83% (95% CI -7.03 to -8.70; p<0.001). Additionally, the proportions of cases with good clinical outcomes (47.8% vs 50.0%, p=0.739) and all-cause death rates (17.7% vs 18.8%, p=0.700) were similar in both groups at 90 days.</p><p><strong>Conclusions: </strong>The Catfish stent retriever is an effective and safe device for endovascular recanalisation in ELVO stroke.</p><p><strong>Trial registration number: </strong>NCT03820882.</p>\",\"PeriodicalId\":22021,\"journal\":{\"name\":\"Stroke and Vascular Neurology\",\"volume\":\" \",\"pages\":\"435-443\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2023-12-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800261/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Stroke and Vascular Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1136/svn-2022-002036\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Stroke and Vascular Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/svn-2022-002036","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

背景:Catfish支架回取器是一种新开发的机械血栓切除装置,用于快速再通畅急诊大血管闭塞(ELVO)卒中。目前的试验旨在评估 Catfish 支架取栓器与 Solitaire 支架取栓器相比,在 ELVO 中风的治疗效果方面是否无差别:这是一项随机、前瞻、平行组、多中心、开放标签、非劣效性研究,在中国的18个地点进行。主要研究结果是手术后成功再通的病例比例(改良脑梗塞溶栓评分 2b 或 3 分)。次要疗效指标包括24小时和7天后的美国国立卫生研究院脑卒中量表评分(如果出院时间更早)、从动脉穿刺到成功再通的时间以及90天后的良好临床疗效(改良Rankin量表评分≤2)。安全性结果包括90天内无症状性颅内出血、全因死亡和严重不良事件:2019年3月3日至2021年6月5日期间,118名和120名患者分别被随机分配到Catfish组和Solitaire组。所有血管内手术后的主要终点,鲶鱼组(88.5%,100/113)不劣于纸牌组(87.7%,100/114),比率差异(RD)为0.78%(95% CI -7.64 至 -9.20;P=0.001)。仅考虑按协议组的敏感性分析也得出了类似的结果,RD 为 0.83%(95% CI -7.03 至 -8.70;p 结论:Catfish支架回取器是一种用于ELVO卒中血管内再通术的有效而安全的设备:试验注册号:NCT03820882。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comparing a novel Catfish flow restoration device and the Solitaire stent retriever for thrombectomy revascularisation in emergent largevessel occlusion stroke: a prospective randomised controlled study.

Background: The Catfish stent retriever is a newly developed mechanical thrombectomy device for rapid recanalisation in emergent large vessel occlusion (ELVO) stroke. The current trial aimed to assess whether the Catfish stent retriever is non-inferior to the Solitaire stent retriever in terms of outcomes in ELVO stroke.

Methods: This was a randomised, prospective, parallel-group, multicentre, open-label, non-inferiority study conducted at 18 sites in China. The primary outcome was the proportion of cases with successful recanalisation (modified thrombolysis in cerebral infarction score of 2b or 3) following the procedure. Secondary efficacy outcomes included the National Institutes of Health Stroke Scale scores at 24 hours and 7 days or discharge if earlier, time from artery puncture to successful recanalisation and good clinical outcome (modified Rankin scale score ≤2) at 90 days. Safety outcomes included symptomatic intracranial haemorrhage, all cause-death and severe adverse events at 90 days.

Results: Between 3 March 2019 and 5 June 2021, 118 and 120 patients were randomly allocated to the Catfish and Solitaire groups, respectively. The primary endpoint after all endovascular procedures was non-inferior in the Catfish group (88.5%, 100/113) than in the Solitaire group (87.7%, 100/114), with a rate difference (RD) of 0.78% (95% CI -7.64 to -9.20; p=0.001). Sensitivity analysis only considering the per-protocol set also yielded similar results, with an RD of 0.83% (95% CI -7.03 to -8.70; p<0.001). Additionally, the proportions of cases with good clinical outcomes (47.8% vs 50.0%, p=0.739) and all-cause death rates (17.7% vs 18.8%, p=0.700) were similar in both groups at 90 days.

Conclusions: The Catfish stent retriever is an effective and safe device for endovascular recanalisation in ELVO stroke.

Trial registration number: NCT03820882.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Stroke and Vascular Neurology
Stroke and Vascular Neurology Medicine-Cardiology and Cardiovascular Medicine
CiteScore
11.20
自引率
1.70%
发文量
63
审稿时长
15 weeks
期刊介绍: Stroke and Vascular Neurology (SVN) is the official journal of the Chinese Stroke Association. Supported by a team of renowned Editors, and fully Open Access, the journal encourages debate on controversial techniques, issues on health policy and social medicine.
期刊最新文献
Association between stroke subtypes and outcomes of endovascular therapy: a post-hoc analysis of the ANGEL-ASPECT Trial Optimal duration of dual antiplatelet therapy for minor stroke within 72 hours of symptom onset: a prospective cohort study Association between ASPECTS region of infarction and clinical outcome in non-acute large vessel occlusion ischaemic stroke after endovascular recanalisation Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections miR-19-3p/GRSF1/COX1 axis attenuates early brain injury via maintaining mitochondrial function after subarachnoid haemorrhage
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1